Literature DB >> 10694479

Regulation of rheumatoid synovial cell growth by ceramide.

K Migita1, S Honda, S Yamasaki, Y Hirai, T Fukuda, T Aoyagi, M Kita, H Ida, T Tsukada, A Kawakami, Y Kawabe, K Eguchi.   

Abstract

Overgrowth of rheumatoid synoviocytes, which results in joint destruction, is due to impaired balance between cell proliferation and cell death (apoptosis). Ceramide is an important lipid messenger involved in mediating a variety of cell functions including apoptosis. We investigated the effects of ceramide on growth-promoting anti-apoptotic signals in rheumatoid synovial cells. Human synovial cells isolated from patients with rheumatoid arthritis (RA) were stimulated with platelet-derived growth factor (PDGF) in the presence or absence of C2-ceramide. The kinase activity of Akt, MEK, and ERK1/2 was analyzed in PDGF-stimulated synovial cells by Western blot analysis. Pretreatment with C2-ceramide completely inhibited PDGF-induced cell cycle progression of rheumatoid synovial cells. PDGF stimulation induced phosphorylation and activation of Akt, MEK, and ERK1/2 in rheumatoid synovial cells. C2-ceramide inhibited the activation of Akt, MEK and ERK1/2 in PDGF-stimulated synovial cells. Our data demonstrated that inhibition of anti-apoptotic kinases, such as Akt and ERK1/2, may play an important role in ceramide-mediated apoptosis of rheumatoid synovial cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694479     DOI: 10.1006/bbrc.2000.2239

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysis.

Authors:  Hiroaki Ida; Toshiyuki Aramaki; Hideki Nakamura; Keita Fujikawa; Kazuhiko Arima; Mami Tamai; Makoto Kamachi; Katsuya Satoh; Tomoki Origuchi; Atsushi Kawakami; Itaru Furuichi; Yojiro Kawabe; Katsumi Eguchi
Journal:  Cytotechnology       Date:  2009-09-26       Impact factor: 2.058

2.  Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.

Authors:  Calogera M Simonaro; Marina D'Angelo; Xingxuan He; Efrat Eliyahu; Nataly Shtraizent; Mark E Haskins; Edward H Schuchman
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

Review 3.  Killing tumours by ceramide-induced apoptosis: a critique of available drugs.

Authors:  Norman S Radin
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

4.  Causal modeling using network ensemble simulations of genetic and gene expression data predicts genes involved in rheumatoid arthritis.

Authors:  Heming Xing; Paul D McDonagh; Jadwiga Bienkowska; Tanya Cashorali; Karl Runge; Robert E Miller; Dave Decaprio; Bruce Church; Ronenn Roubenoff; Iya G Khalil; John Carulli
Journal:  PLoS Comput Biol       Date:  2011-03-10       Impact factor: 4.475

5.  Elimination of rheumatoid synovium in situ using a Fas ligand 'gene scalpel'.

Authors:  Haidi Zhang; Guangping Gao; Gilda Clayburne; H Ralph Schumacher
Journal:  Arthritis Res Ther       Date:  2005-09-08       Impact factor: 5.156

6.  Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.

Authors:  Hanna Myśliwiec; Anna Baran; Ewa Harasim-Symbor; Barbara Choromańska; Piotr Myśliwiec; Anna Justyna Milewska; Adrian Chabowski; Iwona Flisiak
Journal:  Arch Dermatol Res       Date:  2016-12-17       Impact factor: 3.017

Review 7.  Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis.

Authors:  Jianan Zhao; Ping Jiang; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

Review 8.  Lipidomic Profiling in Synovial Tissue.

Authors:  Roxana Coras; Jessica D Murillo-Saich; Abha G Singh; Arthur Kavanaugh; Monica Guma
Journal:  Front Med (Lausanne)       Date:  2022-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.